Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Wondfo 2019-nCoV Antigen Test (Lateral Flow Method)

K-Number: K241317 · 2024-09-30

Decision Date2024-09-30
Product CodeQYT
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

Wondfo 2019-nCoV Antigen Test (Lateral Flow Method) is a medical device manufactured by Guangzhou Wondfo Biotech Co., Ltd.. It received FDA 510(k) clearance on 2024-09-30 under approval number K241317. The device is classified under product code QYT. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Wondfo 2019-nCoV Antigen Test (Lateral Flow Method)?

Wondfo 2019-nCoV Antigen Test (Lateral Flow Method) is a medical device that received FDA 510(k) clearance on 2024-09-30. It is manufactured by Guangzhou Wondfo Biotech Co., Ltd.. The 510(k) number is K241317.

When was Wondfo 2019-nCoV Antigen Test (Lateral Flow Method) approved by the FDA?

Wondfo 2019-nCoV Antigen Test (Lateral Flow Method) received FDA 510(k) clearance on 2024-09-30, under approval number K241317.

What company makes Wondfo 2019-nCoV Antigen Test (Lateral Flow Method)?

Wondfo 2019-nCoV Antigen Test (Lateral Flow Method) is manufactured by Guangzhou Wondfo Biotech Co., Ltd..

What is the FDA product code for Wondfo 2019-nCoV Antigen Test (Lateral Flow Method)?

The FDA product code for Wondfo 2019-nCoV Antigen Test (Lateral Flow Method) is QYT.

Related Clinical Trials

Other Devices by Guangzhou Wondfo Biotech Co., Ltd.

View all 10 devices →

Related Devices (Code: QYT)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.